September 2013

FDA Warning and Removal of Rosiglitazone From VA National Formulary

September 19, 2013


After the FDA warning and removal of rosiglitazone from the VA National Formulary, glucose control may have declined among those discontinuing rosiglitazone without receiving replacement medication.

Out-of-Pocket Costs and Prescription Reversals With Oral Linezolid

September 18, 2013


Associations between out-of-pocket costs and prescription reversals, as well as impact of reversals on rehospitalizations and healthcare costs, were examined among patients prescribed oral linezolid.

Referring Patients for Telephone Counseling to Promote Colorectal Cancer Screening

September 16, 2013


In this pilot study, primary care providers refer patients to a telephone counselor who provides education about colorectal cancer screening and performs motivational interviewing as needed to promote screening.

Testimonials Do Not Convert Patients From Brand to Generic Medication

September 11, 2013


We conducted a randomized controlled trial to assess whether adding a peer testimonial to a mailing increases conversion rates from brand name prescription medications to lower-cost equivalents.